Affimed N.V. AFMD

Quarterly report 2022-Q2
added 08-11-2022

Affimed N.V. DIO Ratio 2011-2026 | AFMD

Annual DIO Ratio Affimed N.V.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	69.8	83.2	88.5	69.9	92.3	86.9	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
92.3	69.8	81.8

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Aquestive Therapeutics AQST	120	$ 3.88	-1.27 %	$ 415 M	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Amphastar Pharmaceuticals AMPH	166	$ 19.23	-	$ 899 M	USA
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	bluebird bio BLUE	125	-	-	$ 546 M	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	CollPlant Biotechnologies Ltd. CLGN	130	$ 0.71	17.15 %	$ 8.13 M	Israel
	Cyclacel Pharmaceuticals CYCC	185	-	-5.98 %	$ 34.1 M	USA
	Aytu BioScience AYTU	209	$ 2.65	0.76 %	$ 16.6 M	USA
	Dynavax Technologies Corporation DVAX	455	-	-	$ 2.02 B	USA
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	Eton Pharmaceuticals ETON	150	$ 22.97	-3.53 %	$ 618 M	USA
	Exelixis EXEL	96.1	$ 41.57	0.39 %	$ 11.3 B	USA
	Fortress Biotech FBIO	215	$ 2.92	-2.01 %	$ 60.7 M	USA